ArticleThe Journal of antimicrobial chemotherapy2025
Reliability of disc diffusion testing and molecular epidemiology of penicillin-susceptible Staphylococcus aureus bacteraemia.
Article in The Journal of antimicrobial chemotherapy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundRecent studies have reported an increasing prevalence of penicillin-susceptible Staphylococcus aureus (PSSA) worldwide. The reliability of disc diffusion testing for detecting penicillin-resistance has been questioned, and the molecular epidemiology of PSSA has not been studied to the same extent as that of MRSA strains.
objectivesTo investigate the reliability of the disc diffusion method for detecting penicillin-resistance in S. aureus, and to examine the prevalence and molecular epidemiology of PSSA in bloodstream infections.
methodsA total of 258 bacteraemic isolates obtained from one geographic region in Sweden during 2018-2019 were analysed using the disc diffusion test to detect penicillin-resistance, and genome sequenced to examine the prevalence of the blaZ gene and the molecular epidemiology of PSSA.
resultsPhenotypic susceptibility to penicillin correlated strongly with the absence of the blaZ gene, with nearly 98% concordance. The prevalence of PSSA among patients with bacteraemia was 35.1%, highlighting the need for penicillin-susceptibility testing. Additionally, population structure analyses revealed substantial genetic diversity, underscoring the complexity of the PSSA epidemiology. The PSSA belonged to diverse clonal lineages, with CC5 and CC45 dominating our cohort, similar to findings in Spain, Australia, and other parts of Sweden. However, our study revealed a higher prevalence of CC12 compared with other regions, underscoring the importance of local epidemiological surveillance.
conclusionsThese findings validate the reliability of EUCAST's disc diffusion method, showing a high prevalence of PSSA, and provide insight into the genetic underpinnings of penicillin-susceptibility in S. aureus.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.